THERAPASE
USPTO Trademark Record · Serial No. 77306027
Trademark details
It was initially claimed by BAYER PHARMA AKTIENGESELLSCHAFT on 20071017.
That brand applies to the following goods and services:Biochemical substances for scientific and research use, namely, proteins and nucleic acids with enzyme and ribozyme properties; assays for molecular-biological research, namely, kits composed of chemical reagents for non-medical purposes, Pharmaceutical products based on active proteins and nucleic acids for use in treating autoimmune and inflammation diseases, diseases of the blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology dise, Scientific research and development in the field of molecular biology and providing advice on a contractual bases relating to scientific developments in molecular biology; scientific research and development of molecular-biological assays; scientific research and development of medicine and environmental analysis; scientific research and development in the fields of biological active substances and biotechnology.
Currently that trademark is represented by trademark attorney(s): Jeffrey M. Gitchel.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the THERAPASE trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
